CT + ADT vs. 3D-CRT + ADT for first-line treatment of “high-risk” prostate cancer

Posted on September 3, 2010 by Sitemaster

A South Korean research team has just published data from a small, prospective, case-matched study comparing outcomes after cryotherapy + androgen deprivation therapy (CT + ADT) to outcomes after three-dimensional conformal radiation therapy + androgen deprivation (3D-CRT + ADT) in patients with high-risk prostate cancer.

Filed under: Management, Treatment | Tagged: , , , , , , , , | Leave a Comment »

“Is there an optimal management for localized prostate cancer?”

Posted on September 3, 2010 by Sitemaster

Most knowledgeable prostate cancer advocates and educators know that the answer to this question is “No.” The correct answer is that the management of localized prostate cancer needs to take account of the characteristics, objectives, and expectations of each individual patient, including his overall health and quality of life.

Filed under: Management, Treatment | Tagged: , , , | 8 Comments »

Immediate vs. deferred radical prostatectomy for localized prostate cancer

Posted on September 2, 2010 by Sitemaster

A retrospective analysis of data from the Swedish National Prostate Cancer Register suggests that deferring radical prostatectomy for a year or more has minimal impact on prostate cancer-specific survival for men with localized prostate cancer.

Filed under: Management, Treatment | Tagged: , , , | 7 Comments »

The natural history of low-risk prostate cancer

Posted on September 2, 2010 by Sitemaster

In a presentation given at the annual meeting of the American Urology Association earlier this year, researchers from Memorial Sloan-Kettering Cancer Center (MSKCC) provided some interesting data on the natural history of prostate cancer in patients initially diagnosed with low-risk disease.

Filed under: Uncategorized | Tagged: , , , , | 3 Comments »

The “empowered” patient — an article in USA Today

Posted on September 1, 2010 by Sitemaster

An article by Mary Brophy Marcus in USA Today discusses the role of the patient today in acting as his or her own advocate when it comes to testing, costs, and health care decisions.

Filed under: Uncategorized | Leave a Comment »

A Presidential Proclamation for Prostate Cancer Awareness Month

Posted on September 1, 2010 by Sitemaster

We are pleased to note that the following Presidential Proclamation was issued by the White House yesterday:

Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention, Risk | Leave a Comment »

Does taking a statin lower PSA in men being tested for prostate cancer risk?

Posted on September 1, 2010 by Sitemaster

Ever since it was recognized that there might be an association between taking statins (as a preventive treatment for elevated cholesterol levels) and risk for prostate cancer (which is now disputed), there has been an associated question as to whether men taking statins generally had a lower PSA level than men who were not, and [...]

Filed under: Diagnosis, Prevention, Risk | Tagged: , , , , | 1 Comment »

« Previous Page
Follow

Get every new post delivered to your Inbox.

Join 249 other followers